title: Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.
abstract: The objective of this work is to verify the incidence of incidental prostate adenocarcinoma in patients who underwent radical cystoprostatectomy for invasive bladder carcinoma. We have retrospectively reviewed patients who underwent radical cystoprostatectomy for infiltrative bladder tumors in period between 2003 and 2007 year, 94 men with bladder cancer underwent radical cystoprostatectomy at Urology Clinic-University of Sarajevo Clinics Centre. Mean age of patients was 67 years, with age limits ranging between 48 and 79 years. Pathohistological evaluation was used for all specimens from RCP. We found that 9,57% of cystoprostatectomy specimens in patients with bladder cancer also contained incidental prostate cancer. This result was much lower than overall mean frequency of incidentally detected prostate cancer in other series of cystoprostatectomy cases (range, 23%-68%). In conclusion we recommended digital rectal examination (DRE) and prostate-specific antigen (PSA) test as part of the bladder cancer work up and complete removal of the prostate at cystoprostatectomy to prevent residual prostate cancer.
authors.affiliation: Urology Clinic, University of Sarajevo Clinics Centre, Sarajevo, Bosnia and Herzegovina.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Hiros
authors.forename: Hajrudin
authors.initials: H
authors.lastname: Spahović
authors.forename: Mirsad
authors.initials: M
authors.lastname: Selimović
authors.forename: Sabina
authors.initials: S
authors.lastname: Sadović
mesh_terms: D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000601:surgery; D015653:Cystectomy / Q000379:methods*; D051517:Digital Rectal Examination; D006801:Humans; D033162:Incidental Findings; D008297:Male; D008495:Medical Oncology / Q000379:methods; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000096:biosynthesis; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000150:complications* / Q000175:diagnosis* / Q000378:metabolism; D012189:Retrospective Studies; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000150:complications* / Q000601:surgery*
chemical_list: D017430:Prostate-Specific Antigen